These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 32847912

  • 1. Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.
    Quist JS, Jensen MM, Clemmensen KKB, Pedersen H, Bjerre N, Størling J, Blond MB, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Færch K.
    BMJ Open; 2020 Aug 26; 10(8):e037166. PubMed ID: 32847912
    [Abstract] [Full Text] [Related]

  • 2. Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
    Quist JS, Pedersen HE, Jensen MM, Clemmensen KKB, Bjerre N, Ekblond TS, Uldal S, Størling J, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Nyeland ME, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Blond MB, Færch K.
    Lancet Healthy Longev; 2024 May 26; 5(5):e314-e325. PubMed ID: 38588687
    [Abstract] [Full Text] [Related]

  • 3. Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial).
    Færch K, Amadid H, Nielsen LB, Ried-Larsen M, Karstoft K, Persson F, Jørgensen ME.
    BMJ Open; 2017 Jun 06; 7(5):e013802. PubMed ID: 28592573
    [Abstract] [Full Text] [Related]

  • 4. Effects of a carbohydrate-reduced high-protein diet delivered with meal kits to Danish people with type 2 diabetes: protocol for a 12-month randomised controlled trial.
    Kopp LHP, Søgaard-Hansen CM, Zachhau KM, Bastkjær RM, Andersen BV, Budtz-Jørgensen E, Byrne DV, Chaaban N, Holst JJ, Klindt TB, Magkos F, Ozenne B, Samkani A, Skytte MJ, Madsbad S, Krarup T, Thomsen MN.
    BMJ Open; 2024 Aug 13; 14(8):e084686. PubMed ID: 39142677
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of time-restricted eating and behavioural economic interventions in reducing fasting plasma glucose, HbA1c and cardiometabolic risk factors compared with time-restricted eating alone or usual care in patients with impaired fasting glucose: protocol for an open-label randomised controlled trial.
    Suthutvoravut U, Anothaisintawee T, Boonmanunt S, Pramyothin S, Chaithanasarn A, Reutrakul S, Thakkinstian A.
    BMJ Open; 2022 Sep 20; 12(9):e058954. PubMed ID: 36127075
    [Abstract] [Full Text] [Related]

  • 6. Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes.
    Ewers B, Bruun JM, Vilsbøll T.
    BMJ Open; 2019 Nov 21; 9(11):e032893. PubMed ID: 31753900
    [Abstract] [Full Text] [Related]

  • 7. Protocol for a multicentre, parallel, randomised, controlled trial on the effect of sweeteners and sweetness enhancers on health, obesity and safety in overweight adults and children: the SWEET project.
    Kjølbæk L, Manios Y, Blaak EE, Martínez JA, Feskens EJM, Finlayson G, Andersen SSH, Reppas K, Navas-Carretero S, Adam TC, Hodgkins CE, Del Álamo M, Lam T, Moshoyiannis H, Halford JCG, Harrold JA, Raben A.
    BMJ Open; 2022 Oct 12; 12(10):e061075. PubMed ID: 36223962
    [Abstract] [Full Text] [Related]

  • 8. Development and feasibility testing of a time-restricted eating intervention for women living with overweight/obesity and HIV in a resource-limited setting of South Africa.
    Hoosen F, Pico ML, Goedecke JH, Dave JA, Quist JS, Færch K, Grunnet LG, de Villiers A, Aagaard-Hansen J, Mendham AE.
    BMC Public Health; 2024 Oct 10; 24(1):2768. PubMed ID: 39390498
    [Abstract] [Full Text] [Related]

  • 9. UPDATE trial: investigating the effects of ultra-processed versus minimally processed diets following UK dietary guidance on health outcomes: a protocol for an 8-week community-based cross-over randomised controlled trial in people with overweight or obesity, followed by a 6-month behavioural intervention.
    Dicken S, Makaronidis J, van Tulleken C, Jassil FC, Hall K, Brown AC, Gandini Wheeler-Kingshott CAM, Fisher A, Batterham R.
    BMJ Open; 2024 Mar 11; 14(3):e079027. PubMed ID: 38471681
    [Abstract] [Full Text] [Related]

  • 10. Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.
    Johansen NJ, Dejgaard TF, Lund A, Vilsbøll T, Andersen HU, Knop FK.
    BMJ Open; 2018 Jun 27; 8(6):e021861. PubMed ID: 29950475
    [Abstract] [Full Text] [Related]

  • 11. Isolated and combined effects of high-intensity interval training and time-restricted eating on glycaemic control in reproductive-aged women with overweight or obesity: study protocol for a four-armed randomised controlled trial.
    Moholdt T, Silva CP, Lydersen S, Hawley JA.
    BMJ Open; 2021 Feb 05; 11(2):e040020. PubMed ID: 33550228
    [Abstract] [Full Text] [Related]

  • 12. Time-Restricted Eating as a Nutrition Strategy for Individuals with Type 2 Diabetes: A Feasibility Study.
    Parr EB, Devlin BL, Lim KHC, Moresi LNZ, Geils C, Brennan L, Hawley JA.
    Nutrients; 2020 Oct 22; 12(11):. PubMed ID: 33105701
    [Abstract] [Full Text] [Related]

  • 13. Guided self-determination intervention versus attention control for people with type 2 diabetes in outpatient clinics: a protocol for a randomised clinical trial.
    Mathiesen AS, Zoffmann V, Skytte TB, Jakobsen JC, Gluud C, Lindschou J, Rasmussen B, Marqvorsen E, Thomsen T, Rothmann M.
    BMJ Open; 2021 Dec 23; 11(12):e047037. PubMed ID: 34949603
    [Abstract] [Full Text] [Related]

  • 14. Effect of time restricted eating versus current practice in dietetics on glycaemic control and cardio-metabolic outcomes in individuals at risk of developing type 2 diabetes: Protocol for a multi-centre, parallel group, non-inferiority, randomised controlled trial.
    Charrouf R, Parr EB, Hutchison AT, Flint SA, Teong XT, Wittert G, Vincent AD, Brennan L, Devlin BL, Hawley JA, Heilbronn LK.
    Contemp Clin Trials; 2024 Sep 17; 146():107696. PubMed ID: 39299545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trial.
    Ganeshalingam AA, Uhrenholt NG, Arnfred S, Gæde PH, Bilenberg N, Frystyk J.
    BMJ Open; 2024 Mar 18; 14(3):e077173. PubMed ID: 38503415
    [Abstract] [Full Text] [Related]

  • 17. A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
    Brown E, Wilton MM, Sprung VS, Harrold JA, Halford JCG, Stancak A, Burgess M, Howarth E, Umpleby AM, Kemp GJ, Wilding JP, Cuthbertson DJ.
    BMJ Open; 2021 Jul 20; 11(7):e045663. PubMed ID: 34285005
    [Abstract] [Full Text] [Related]

  • 18. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
    Skytte MJ, Samkani A, Petersen AD, Thomsen MN, Astrup A, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Larsen TM, Haugaard SB, Krarup T.
    Diabetologia; 2019 Nov 20; 62(11):2066-2078. PubMed ID: 31338545
    [Abstract] [Full Text] [Related]

  • 19. Time-restricted eating to improve cardiometabolic health: The New York Time-Restricted EATing randomized clinical trial - Protocol overview.
    Santos-Báez LS, Garbarini A, Shaw D, Cheng B, Popp CJ, Manoogian ENC, Panda S, Laferrère B.
    Contemp Clin Trials; 2022 Sep 20; 120():106872. PubMed ID: 35934281
    [Abstract] [Full Text] [Related]

  • 20. The PULSE (Prevention Using LifeStyle Education) trial protocol: a randomised controlled trial of a Type 2 Diabetes Prevention programme for men.
    Aguiar EJ, Morgan PJ, Collins CE, Plotnikoff RC, Young MD, Callister R.
    Contemp Clin Trials; 2014 Sep 20; 39(1):132-44. PubMed ID: 25092484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.